Enzo Life Sciences SuperFasLigand for enhanced immune activation
The critical role of signals transmitted via TNF ligands and receptors in mediating inflammation, cancer and immunity are well established. Recombinant TNF ligands can be used in drug development to enhance immune activation. Oligomerisation of TNF ligands using enhancers and expression of self-oligomerising chimeric proteins have been shown to improve stability and significantly enhance immune activation compared to that achieved with recombinant ligands alone.
SuperFasLigand is soluble, human and recombinant. It is said to provide enhanced immune activation compared to other recombinant ligands. The product features an N-terminus linker shown to improve stability and mimics glycosylation of native human FasL.
Phone: 02 4575 0309
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
Azure Biosystems Ao Microplate Reader
The 96-well Ao Microplate Reader from Azure Biosystems offers a multitude of features to help...
Navinci Naveni Plex isPLA multiplex solution
The isPLA multiplex solution is designed to simultaneously detect PD1/PD-L1 interactions...
